EUVIMEDEUVIMED entdecken
Open Access

Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation

Haixi You iD, Larissa Havey iD, Zhixuan Li iD, Yin Wang iD, John M Asara iD, Rui Guo iD

Science Advances · 2025

DOI: 10.1126/sciadv.adr8837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Haixi You und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA. Hauptthemen laut MEDLINE: Cardiolipins, Herpesvirus 4, Human, B-Lymphocytes, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Epstein-Barr virus (EBV) infects nearly 90% of adults globally and is linked to over 200,000 annual cancer cases. Immunocompromised individuals from conditions such as primary immune disorders, HIV, or posttransplant immunosuppressive therapies are particularly vulnerable because of EBV’s transformative capability. EBV remodels B cell metabolism to support energy, biosynthetic precursors, and redox equivalents necessary for transformation. Most EBV-driven metabolic pathways center on mitochondria. However, how EBV regulates B cell mitochondrial function and metabolic fluxes remains unclear. Here, we show that EBV boosts cardiolipin (CL) biosynthesis, essential for mitochondrial cristae biogenesis, via EBV nuclear antigen 2/MYC-induced CL enzyme transactivation. Pharmacological and CRISPR genetic analyses underscore the essentiality of CL biosynthesis in EBV-transformed B cells. Metabolomic and isotopic tracing highlight CL’s role in sustaining respiration, one-carbon metabolism, and aspartate synthesis. Disrupting CL biosynthesis destabilizes mitochondrial matrix enzymes pivotal to these pathways. We demonstrate EBV-induced CL metabolism as a therapeutic target, offering synthetic lethal strategies against EBV-associated B cell malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiolipinsHerpesvirus 4, HumanB-LymphocytesEpstein-Barr Virus InfectionsCell Transformation, ViralHumansMitochondria

Substanzen

Cardiolipins

Autor:innen und Institutionen

  • Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA.
  • Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA.
  • Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Haixi You, Larissa Havey, Zhixuan Li, Yin Wang, John M Asara, Rui Guo

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS

Zitieren

APA

You, H., Havey, L., Li, Z., Wang, Y., Asara, J. M., & Guo, R. (2025). Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation. Science Advances. https://doi.org/10.1126/sciadv.adr8837

Vancouver

You H, Havey L, Li Z, Wang Y, Asara JM, Guo R. Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation. Science Advances. 2025. doi:10.1126/sciadv.adr8837

BibTeX
@article{You2025,
  author = {You, Haixi and Havey, Larissa and Li, Zhixuan and Wang, Yin and Asara, John M and Guo, Rui},
  title = {Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adr8837}
}
Kostenlos starten →